Reported Aug 12, 2015 · Terminated
Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY…
Ranbaxy Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Ranbaxy Inc. · 600 College Rd E Ste 2100 · Princeton, NJ · 08540-6636
Is this the product you have?
- Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only
- Manufactured forRANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA
- NDC10631-133-31
- Lot codes and dates
- Lot #:14H04AA
- Expiry02/28/2017
- Amount recalled
- 9,229 Boxes
Where it was sold
- Nationwide
Why it was recalled
Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new undeclared allergens recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.